Inhaled Tobramycin Effectively Reduces FEV(1) Decline in Cystic Fibrosis. An Instrumental Variables Analysis

Rationale: The efficacy of inhaled tobramycin on chronic Pseudomonas aeruginosa infections in patients with cystic fibrosis (CF) has been established in clinical trials. However, little is known about its clinical effectiveness on lung function outside randomized controlled trial settings; conventio...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Ann Am Thorac Soc
Auteurs principaux: VanDyke, Rhonda D., McPhail, Gary L., Huang, Bin, Fenchel, Matthew C., Amin, Raouf S., Carle, Adam C., Chini, Barb A., Seid, Michael
Format: Artigo
Langue:Inglês
Publié: American Thoracic Society 2013
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5475429/
https://ncbi.nlm.nih.gov/pubmed/23802816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1513/AnnalsATS.201209-082OC
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires